1kits (10Vials) .
| Nusiwo li: | |
|---|---|
| Agbɔsɔsɔ: | |
▎ Nukae nye MOTs-C?
MOTs-C nye peptide si wokpɔ tso mitochondrial me si woŋlɔ ɖe mitochondrial DNA ƒe 12S rRNA nuto me, si me amino acid 16 le. Abe mitochondrial retrograde signal ene la, MOTs-C ate ŋu aʋu ayi lãmenugbagbeviwo ƒe nucleus me le nɔnɔmewo abe metabolic stress ene me, si aɖɔ domenyiŋusẽfianu siwo kplɔ wo nɔewo ɖo siwo do ƒome kple metabolic dysfunction ƒe ɖeɖefia ɖo. Ekaka ɖe ŋutinu vovovowo abe ayiku, dzi ƒe lãmeka, kple ƒunukpeƒe ƒe lãmeka ene me ŋutɔ, eye wòle ʋumenugbagbeviɣi hã me. Ate ŋu atso ʋu kple ahɔhɔ̃ ƒe mɔxenu eye wòaɖɔ lãmenugbagbeviwo ƒe ŋusẽ ƒe dadasɔ, sukli, kple ami ƒe suklidɔ ɖo to AMPK mɔa ƒe dɔwɔwɔ me, si wɔa akpa vevi aɖe le lãmenugbagbeviwo ƒe lãmesẽ me léle ɖe asi me. Ekpɔa ŋusẽ ɖe insulin ƒe dɔlélenutsiŋutete dzi ɖeɖe kpɔtɔ, mɔxexe ɖe suklidɔ ƒomevi evelia nu, suklidɔ si me ami le ƒe ɖoɖowɔwɔ, kple dzitodzito kple ahɔhɔ̃mekawo ƒe lãmesẽ takpɔkpɔ me.
▎ MOTs-CStructure ƒe ɖoɖo
Dzɔtsoƒe: PubChem |
Nusiwo kplɔ wo nɔewo ɖo: MRWQEMGYIFYPRKLR Molekyulãwo ƒe Mɔfiame: C101H152N28O22S2 Molekyulã ƒe Kpekpeme: 2174.6g/mol CAS ƒe xexlẽdzesi: 1627580-64-6 PubChem ƒe CID: 146675088 Nya siwo sɔ kple wo nɔewo: UNII-A5CV6JFB78 |
▎ MOTs-C Numekuku
Nukae nye numekuku si wowɔ le MOTs-C ŋu?
MOTs-C ƒe numekuku ƒe gɔmedzedze dzɔ tso numekuku siwo wowɔ le akpa si mitochondrial DNA wɔna le lãmenugbagbeviwo ƒe lãmesẽ kple tsitsi me ŋu. Esi mitochondria ƒe dɔwɔwɔ gɔmesese va nɔ sesẽm ɖe edzi la, wokpɔe be menye ŋusẽ ƒe suklidɔ ƒe titina koe mitochondria nye o, ke ekpɔa gome le lãmenugbagbeviwo ƒe kadodo kple dzesiwo ƒe tɔtrɔ hã me. To AMPK mɔa ƒe dɔwɔwɔ me la, wokpɔa gome le suklidɔ kple ami ƒe suklidɔ me, si do ƒome kplikplikpli kple lãmenugbagbeviwo ƒe dɔwɔwɔ abe suklidɔ kple lolo akpa ene, eye wodo ŋugbe be wonye atikewɔwɔ ƒe taɖodzinu yeyewo na nɔnɔme siawo. Esi wònye be kadodo le mitochondria ƒe dɔwɔwɔ kple dɔléle vovovowo dome ta la, wozã MOTs-C hã le nɔnɔmewo abe aklãdɔléle B si nɔa anyi didi kple azigolo me kansa ene me. Numekukuwo ɖee fia be ate ŋu awɔ akpa vevi aɖe le dɔlékuiwo ƒe dɔlékuiwo xɔxɔ ƒe ɖoɖowo me. Kamedede doa MOTs-C ƒe wɔwɔme kple eɖeɖefia ɖe ŋgɔ le amegbetɔ ƒe ŋutilã me, si wɔnɛ be lãmekawo ƒe suklidɔ, ŋutilã ƒe dɔwɔwɔ, kple ŋutilã ƒe dɔwɔwɔ bliboa nyona ɖe edzi, si naa kpeɖodzi na tsitsi ƒe mɔnu siwo wotu ɖe kamedede dzi eye wòkekea MOTs-C ƒe numekuku ƒe lolome ɖe enu.
Nukae nye MOT-C ƒe dɔwɔwɔ ƒe mɔnu?
AICAR-AMPK ƒe dzesimɔa ƒe dɔwɔwɔ:
MOTs-C wɔa eƒe ŋutilã ƒe dɔwɔwɔwo koŋ to AICAR-AMPK dzesimɔa ƒe dɔwɔwɔ me. Egblẽa folate-methionine ƒe tsatsam le lãmenugbagbeviwo me, si wɔnɛ be AICAR-AMPK ƒe dzesimɔa wɔa dɔ. Le kpɔɖeŋu me, le ŋutilã ƒe dɔwɔwɔwo abe insulin ƒe dɔlélenutsiŋutete ƒe nyonyo kple mɔxexe ɖe lolo akpa nu me la, mɔ sia ƒe dɔwɔwɔ wɔa akpa vevi aɖe. To mɔ sia ƒe dɔwɔwɔ me la, MOTs-C ate ŋu aɖɔ lãmenugbagbeviwo ƒe ŋusẽ suklidɔ ɖo, ana lãmenugbagbeviwo ƒe sukli ƒe xɔxlɔ̃ kple eŋudɔwɔwɔ nanyo ɖe edzi, si ana wòaɖɔ ɖoɖowɔɖi ƒe lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe homeostasis ɖo [1,2]..
Kadodo kple dzesimɔ kple domenyiŋusẽfianu tɔxɛwo:
Le lãmekawo me la, MOTs-C wɔa dɔ kple dzesiwo ƒe tɔtrɔ kple nuŋɔŋlɔ ƒe dɔwɔwɔ 3 (STAT3) to eƒe YIFY domenyiŋusẽfianu ƒe Src-homologous 2 (SH2) binding motif si wosusu be, si ɖea STAT3 ƒe nuŋɔŋlɔ ƒe dɔwɔwɔ dzi kpɔtɔna eye wòdoa myotube wɔwɔ ɖe ŋgɔ. Le keklẽŋusẽ ƒe aklãdɔléle me la, MOTs-C ɖea lãkusiwo ƒe gbegblẽ, dɔdzẽ, kple oxidative stress dzi kpɔtɔna to nuklia factor E2-related factor (Nrf2) ƒe agbɔsɔsɔ dzi ɖeɖe kpɔtɔ kple eƒe nuklia ƒe ʋuʋu dodo ɖe ŋgɔ me, si wɔnɛ be wòkpɔa mitochondria ƒe dɔwɔwɔ ta. Tsɔ kpe ɖe eŋu la, MOTs-C wɔa ŋutilã ƒe dɔwɔwɔ vovovowo to domenyiŋusẽfianuwo abe GLUT4, STAT3, kple IL-10 ƒe ɖeɖefia dzi kpɔkpɔ me [3]..
Lãmetsiŋusẽ ƒe mɔwo dzi kpɔkpɔ:
MOTs-C kpɔa gome le lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe ɖoɖo vevi vovovowo dzi kpɔkpɔ me, siwo dometɔ aɖewoe nye suklidɔ si me suklidɔ le, suklidɔ si me ami le, kple suklidɔ le ƒu me, to autocrine kple paracrine mɔnuwo dzi. Le suklidɔ si me suklidɔ le me la, enaa insulin ƒe dɔlélenutsiŋutete nyona ɖe edzi eye wònaa sukli ƒe agbɔsɔsɔ le ʋu me nɔa ɖoɖo nu; le suklidɔ si me ami le me la, enaa ami ɣiwo ƒe dzoxɔxɔ dzina ɖe edzi, edoa ami ɣiwo ƒe amadede dzẽ ɖe ŋgɔ, eye wòxea mɔ na lolo akpa kple suklidɔ si me ami le ƒe dɔlélewo; le ƒume suklidɔ me la, edoa ƒumeŋuɖuiwo ƒe dzidziɖedzi, vovototodedeameme, kple mineralization ɖe ŋgɔ, exea mɔ na ƒumeŋuɖuiwo ƒe dzidzi, eye wòɖɔa ƒumeŋuɖui kple ƒuwo ƒe gbugbɔgaɖɔɖo ɖo [4,5]..

Figure 1 MOTs-C ƒe dɔwɔwɔ kple dɔwɔwɔ [6] ..
Nukae nye MOTs-C ƒe dɔwɔwɔwo kple wo zazã?
MOT-wo ƒe dɔwɔwɔwo-C
Dɔwɔwɔ ɖe suklidɔ dzi le ɖoɖowɔwɔ me:
MOTs-C ate ŋu ana suklidɔ kple ʋumemi ƒe suklidɔ nanyo ɖe edzi le ŋutilã me. Le suklidɔ si me suklidɔ le me la, eɖea insulin ƒe dɔlélenutsiŋutete dzi kpɔtɔna, ekpena ɖe ame ŋu be woaxe mɔ ɖe suklidɔ ƒomevi evelia nu, eye wònaa lãmenugbagbeviwo ƒe suklidɔ xɔxɔ kple eŋudɔwɔwɔ nyuie nyona ɖe edzi. Le suklidɔ si me ami le me la, enaa ami ɣi ƒe dzoxɔxɔ ƒe dzɔdzɔ dzina ɖe edzi, edoa ami ɣi ƒe blɔ ɖe ŋgɔ, si wɔnɛ be ami ƒe suklidɔ nɔa ɖoɖo nu, xea mɔ na lolo akpa, kple ami ƒe asitɔtrɔ ƒe kuxi siwo do ƒome kplii. Eɖea aklãdɔ si me ami mele o ƒe dzɔdzɔ hã dzi kpɔtɔna eye wòɖɔa aklã me ʋumemi ƒe suklidɔ ɖo [2] ..
Ŋusẽ si wòkpɔna ɖe lãmenugbagbeviwo ƒe dɔwɔwɔ dzi:
Edoa mitochondria ƒe dɔwɔwɔ ɖe ŋgɔ eye wòkpɔa lãmenugbagbeviwo ta tso nusiwo agblẽ le wo ŋu me. Le kpɔɖeŋu me, le aklãdɔ si keklẽŋusẽ hena vɛ me la, eɖea mitochondria ƒe gbegblẽ le lãkusi me lãmenugbagbeviwo me dzi kpɔtɔna, eɖea lãmenugbagbeviwo ƒe tsɔtsrɔ̃ dzi kpɔtɔna, eye wònana lãmenugbagbeviwo ƒe dɔwɔwɔ nyuie nɔa anyi. Le dɔgboa ƒe lãmenugbagbeviwo me la, MOTs-C kpɔa ŋusẽ ɖe insulin kple glucagon ƒe dodo kple eɖeɖefia dzi, si kpɔa dɔgboa ƒe lãmenugbagbeviwo ƒe dɔwɔwɔ dzi, eye wòkpɔa ŋusẽ ɖe lãmenugbagbeviwo ƒe agbenɔnɔ kple apoptosis hã dzi [4,5]..
Ŋusẽ si wòkpɔna ɖe lãmekawo kple ƒuwo dzi:
Le lãmekawo me la, MOTs-C doa lãmekawo ƒe lãmenugbagbeviwo ƒe vovototodedeameme ɖe ŋgɔ, enaa myotube ƒe wɔwɔme dzina ɖe edzi, eye wòkpɔa lãmekawo ta tso nusiwo interleukin-6 (IL-6) hena vɛ me, si ate ŋu axe mɔ ɖe lãmekawo ƒe tsɔtsrɔ̃ nu. Le ƒuwo gome la, edoa ƒumeŋuɖuiwo ƒe dzidziɖedzi, vovototodedeameme, kple mineralization ɖe ŋgɔ, exea mɔ na ƒumeŋuɖuiwo ƒe wɔwɔ, ena ƒuwo ƒe lãmenugbagbeviwo ƒe dɔwɔwɔ da sɔ, eye wòkpena ɖe ƒumeŋuɖui ŋu wòhea ƒumeŋuɖui ɖe megbe [1,5]..
Dɔlékuiwutikewo kple dɔlélenutsiŋutete ƒe dɔwɔwɔ:
MOTs-C ɖea dɔdzẽ ƒe ŋuɖoɖo siwo nɔa anyi didi le ɖoɖo nu dzi kpɔtɔna eye wòɖɔa dɔlélenutsiŋutete ƒe dɔwɔwɔ ɖo. Le vevesese ƒe kpɔɖeŋuwo me la, MOTs-C ɖea vevesese ƒe seselelãme si gbɔ eme dzi kpɔtɔna, eɖea dɔdzẽ ƒe nusiwo dona le lãme na ame dzi kpɔtɔna, eye wòxea mɔ na glial lãmenugbagbeviwo kple ahɔhɔ̃mekawo ƒe dɔwɔwɔ, si ɖea dɔdzẽ kple vevesese dzi ɖeɖe kpɔtɔ ƒe ŋusẽkpɔɖeamedzi fiana [3]..
MOT-wo ƒe dɔwɔwɔ-C
Dɔ si wòkpɔna ɖe lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe dɔlélewo dzi:
MOTs-C ƒe ɖoɖowɔwɔ ƒe ŋusẽkpɔɖeamedzi ɖe suklidɔ kple ami ƒe suklidɔ dzi na wònye atikewɔwɔ ƒe taɖodzinu yeye na lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe dɔlélewo abe suklidɔ ƒomevi eve, lolo akpa, kple aklãdɔ si me ami mele o [2]..
Mɔxexe Ðe Lãmetsiŋusẽdɔlélewo Nu Kple Wo Dada:
Woate ŋu azã ŋusẽ nyui si wòkpɔna ɖe lãmekawo kple ƒuwo dzi atsɔ axe mɔ ɖe dɔléle siwo do ƒome kple lãmekawo ƒe tsɔtsrɔ̃ kple ƒunukpeƒetetedɔ abe ƒumeŋuɖui ene nu ahada wo. Le dɔnɔ siwo ƒe lãmekawo me gblẽ gome la, ate ŋu ana lãmekawo ƒe dɔwɔwɔ nanyo ɖe edzi to lãmekawo ƒe lãmenugbagbeviwo ƒe vovototodedeameme dodo ɖe ŋgɔ kple lãmekawo ƒe lãmenugbagbeviwo ƒe tsɔtsrɔ̃ nu; Le dɔnɔ siwo ŋu ƒumeŋuɖui le gome la, ate ŋu ana ƒu ƒe lãmenugbagbeviwo ƒe dɔwɔwɔ nada asɔ, ana ƒu ƒe kpekpeme nadzi ɖe edzi, eye wòaxe mɔ ɖe ƒumeŋuɖui nu ahadae [1,5]..
Kekeli ƒe nugbegblẽ takpɔkpɔ:
Le numekuku siwo wowɔ tso keklẽŋusẽ ƒe aklãdɔléle ŋu me la, MOTs-C ɖee fia be ekpɔa ame ta tso keklẽŋusẽ ƒe nugbegblẽ le lãkusi me ŋu. Woate ŋu azãe le keklẽŋusẽdɔdaɣi atsɔ akpɔ lãkusi siwo sɔ ta, aɖe lãmeka siwo gblẽa nu le keklẽŋusẽ ŋu dzi akpɔtɔ, eye wòana keklẽŋusẽdɔdamɔnu nawɔ dɔ nyuie wu [2] ..
Dɔléle siwo gblẽa nu le ame ŋu ƒe atikewɔwɔ:
Woate ŋu anɔ te ɖe eƒe dɔlékuiwutikewo dzi azã MOTs-C atsɔ ada dɔdzẽ ƒe dɔlélewo abe dɔdzẽ ƒe vevesese ene, si ana mɔfiame yeyewo le nɔnɔme mawo dada ŋu [3]..
Nyanuwuwuw
Abe peptide si wokpɔna tso mitochondria me ene la, MOTs-C ate ŋu ana dzesimɔwo nawɔ dɔ be woaɖɔ sukli kple ami ƒe suklidɔ ɖo, ana insulin ƒe dɔlélenutsiŋutete nanyo ɖe edzi, eye wòaɖe lãmenugbagbeviwo ƒe dɔlélewo ƒe afɔkua dzi akpɔtɔ; ate ŋu alé lãmekawo kple ƒuwo ƒe dɔwɔwɔ hã ɖe te, axe mɔ ɖe lãmekawo ƒe vuvu kple ƒumeŋuɖui nu; eye dɔ siwo tsia dzodzodzoetsitsi nu kple lãmenugbagbeviwo takpɔkpɔ le esi, eye wòwɔa akpa aɖe le keklẽŋusẽ ƒe nugbegblẽ takpɔkpɔ kple dɔdzẽ ƒe dɔlélewo dada me.
Le Agbalẽŋlɔla La Ŋu
Nusiwo míeyɔ ɖe etame la katã nye esiwo ŋu Cocer Peptides wɔ numekuku le, trɔ asi le wo ŋu eye woƒo wo nu ƒu.
Dzɔdzɔmeŋutinunya ƒe Agbalẽŋlɔla
Wan, Yanmin do ƒome kple habɔbɔ xɔŋkɔ vovovowo, siwo dometɔ aɖewoe nye kɔdziwo, numekuku dɔwɔƒewo, yunivɛsitiwo, kple dɔwɔƒewo abe Linping Hosp Integrated Tradit Chinese & Western M, Shanghai Sci Tech Inno Ctr Infect & Immun, Yunnan Agricultural University, kple bubuawo Dzɔdzɔmeŋusẽŋununya. Le Dɔlélenutsiŋutete Ŋuti Nunya & Mɔ̃ɖaŋununya ƒe akpa dzi la, eku nu me tsitotsito le dɔlélenutsiŋutete ƒe dɔwɔwɔ kple eŋudɔwɔwɔ ŋu. Eƒe Dɔlékuiŋutinunya ŋuti numekukuwo ku ɖe dɔlékui ƒe nɔnɔmewo, eƒe kaka, kple mɔxexe ɖe enu ŋu. Le Nuwo ƒe Dzɔdzɔmeŋutinunya ƒe Dzɔdzɔmeŋusẽŋununya ƒe akpaa me la, etsɔ eɖokui na be yeado nuwo ƒe nɔnɔmewo ɖe ŋgɔ eye yeazã atikeŋutinunya le mɔ yeyewo nu, si wɔe be wònye ame ɖedzesi si si numekuku me dzidzedzekpɔkpɔ veviwo le le sukunusɔsrɔ̃ siwo sɔ me. Woŋlɔ Wan, Yanmin ŋkɔ ɖe nyayɔyɔ ƒe nyatakaka me [6].
▎ Nyayɔyɔ Siwo Sɔ
[1] García-Benlloch S, Revert-Ros F, Blesa JR, kple ame bubuwo. MOTs-C doa lãmekawo ƒe vovototodedeameme ɖe ŋgɔ le vitro[J]. Peptides, 2022,155:170840.DOI:10.1016/j.peptidewo.2022.170840.
[2] Zhang Y, Huang J, Zhang Y, kple ame bubuwo. Peptide MOTs-C si wokpɔ tso Mitochondrial me la ɖea keklẽŋusẽ ƒe aklãdɔ dzi kpɔtɔna to mɔnu si nɔa te ɖe Nrf2 dzi dzi[J]. Nusiwo tsia dzoxɔxɔ nu, 2024,13.
[3] Wang Z, Yang L, Xu L, kple ame bubuwo. MOTs-C ƒe titina kple gotagome mɔnu ɖea vevesese ƒe seselelãme si gbɔ eme dzi kpɔtɔna le mice model of inflammatory pain[J]. Ahɔhɔ̃ŋutinunya me Numekuku, 2024, 46 (2): 165-177.DOI: 10.1080 / 01616412.2023.2258584.
[4] Bień J, Pruszyńska-Oszmałek E, Kołodziejski P, kple ame bubuwo. MOTs-C ɖɔa dɔgboa ƒe alpha kple beta lãmenugbagbeviwo ƒe dɔwɔwɔ ɖo le vitro[J]. Lãmetsiŋusẽŋutinunya kple Lãmetsiŋusẽŋutinunya, 2024,161 (6): 449-460.DOI: 10.1007 / s00418-024-02274-0.
[5] Yi X, Hu G, Yang Y, kple ame bubuwo. Akpa si MOTs-C wɔna le ƒumeŋuɖui ƒe suklidɔ dzi kpɔkpɔ me[J]. Liƒowo le Dzɔdzɔmeŋusẽŋununya, 2023, 14: 1149120.DOI: 10.3389 / fphys.2023.1149120.
[6] Wan W, Zhang L, Lin Y, kple ame bubuwo. Mitochondria-derived peptide MOTs-C: ŋusẽkpɔɖeamedzi kple mɔnu siwo ku ɖe nuteɖeamedzi, suklidɔ kple tsitsi ŋu[J]. Gbegɔmeɖeɖe ƒe Atikewɔwɔ ƒe Agbalẽ, 2023, 21 (1): 36.DOI: 10.1186 / s12967-023-03885-2.
NYATAKAKAWO KPLE NUSIWO WOTSƆ ƑE NYATAKAKA SIWO KAtã WOÐO LE NYATAKAKADZRAÐOƑE SIA ME LA KPLE NYATAKAKAWO kaka KPLEE NUFIAFIA ƑE TAÐOÐOWO KO.
Wotrɔ asi le atike siwo wona le nyatakakadzraɖoƒe sia ŋu na numekuku le vitro ɖeɖeko. Wowɔa numekuku le vitro (Latingbe me: *le ahuhɔ̃e me*, si gɔmee nye le ahuhɔ̃e me) le amegbetɔ ƒe ŋutilã godo. Atike siawo menye atikewo o, United States ƒe Nuɖuɖu Kple Atike Ŋuti Dɔwɔƒe (FDA) meda asi ɖe wo dzi o, eye mele be woazã wo atsɔ axe mɔ ɖe atikewɔwɔ, dɔléle, alo dɔléle aɖeke nu, adae, alo adae o. Se de se vevie be woatsɔ atike siawo ade amegbetɔ alo lãwo ƒe ŋutilã me le mɔ ɖesiaɖe nu.